Clinuvel
330 Collins Street
Level 11
Melbourne
Victoria
3000
Tel: 61-3-9660-4900
Fax: 61-3-9660-4999
Website: http://www.clinuvel.com/
32 articles about Clinuvel
-
Clinuvel Announces Positive Results of First Phase II US Study of SCENESSE® in Orphan Disease Erythropoietic Protoporphyria (EPP)
11/3/2011
-
EMA Acknowledges Clinuvel’s Novel Drug Filing in Europe in 2011
5/12/2011
-
Clinuvel Release: FDA Allows World First Vitiligo Drug Trial
3/2/2011
-
Clinuvel Completes First Phase II US Study
2/9/2011
-
Clinuvel Release: Successful Drug Trial Results for Light Intolerant 'Shadow Jumpers'
7/13/2010
-
SurModics Inc. Signs License Agreement With Clinuvel
7/8/2010
-
Clinuvel Novel UV Protecting Drug Delivered By The Picogram
7/8/2010
-
Clinuvel Unveils SCENESSE(R) Following European Brand Approval
5/18/2010
-
Preliminary Results in Clinuvel's Phase III Porphyria Trial
12/21/2009
-
FDA Grants IND Status to Clinuvel's Photoprotective Afamelanotide
1/29/2009
-
Clinuvel Release: Positive Interim Phase III Results For Unique Skin Protection Drug
1/21/2009
-
European Medicines Evaluation Agency Grants Clinuvel Two Orphan Drug Designations
3/13/2008